While immunotherapy drugs such as pembrolizumab, which target the PD-1 molecule, have demonstrated efficacy in treating melanoma and lung cancer, they have not significantly ... used a novel genomics ...

Survival for patients with glioblastoma brain tumour is 12–18 months from diagnosis. Some tumours may respond well to immunotherapy, but there is currently no way to assess response and adapt ...

Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance ...

New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods ...

Researchers have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study used a ...

which promotes CRC formation by increasing cancer stemness. Spatial profiling and single-cell RNA sequencing are used to map the spatial distribution of the microbiota within human tumours ...

We also employed thematic map analysis, co-citation analysis ... Simultaneously, there is an increasing trend in the adjuvant treatment of breast cancer utilizing monoclonal antibodies like ...